1-10 of 10
Patricia A. Young
Close
Sort by
Journal Articles

Deliriogenic Medication Use in Older Adults Receiving CAR-T Correlates with Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)

Michael J. Maranzano, Justin Cheng, John Timmerman, Patricia A. Young, Caspian H. Oliai, Herbert A. Eradat, Sven de Vos, Sarah M. Larson, Monica Mead
Journal: Blood
Blood (2023) 142 (Supplement 1): 7358.
https://doi.org/10.1182/blood-2023-182105
Published: 2023
Journal Articles

Updated Follow-up of a Phase 1 Trial of Bispecific CART19/20 Cells for Relapsed or Refractory Non-Hodgkin Lymphoma

Benjamin R Puliafito, Christopher M Walthers, Brenda Ji, Sanaz N Ghafouri, Jacob Naparstek, Jacqueline Trent, Jia Ming Chen, Mobina Roshandell, Caitlin Harris, Mobina Khericha, Melanie Ayala Ceja, Christy Sidhu, Thomas Schweppe, Beata Berent-Maoz, Stanley B Gosliner, Amr Almaktari, Karla Nawaly, Martin S Allen-Auerbach, Jonathan Said, Monica Mead, Sven de Vos, Patricia A. Young, Caspian H. Oliai, Gary J. Schiller, John Timmerman, Antoni Ribas, Yvonne Y Chen, Sarah M. Larson
Journal: Blood
Blood (2023) 142 (Supplement 1): 3490.
https://doi.org/10.1182/blood-2023-186636
Published: 2023
Journal Articles

Impact of Timing of Autologous Hematopoietic Cell Transplantation in Primary Central Nervous System Lymphoma: A University of California Hematologic Malignancies Consortium Retrospective Analysis

Tamer Othman, Michelle A. Quan, Shiliang Zhang, Daria Gaut, Patricia A. Young, Haifaa Abdulhaq, Kevin Shieh, Jack Reid, Elizabeth A. Brem, Benjamin Heyman, Joseph Tuscano
Journal: Blood
Blood (2022) 140 (Supplement 1): 4851–4852.
https://doi.org/10.1182/blood-2022-163552
Published: 2022
Journal Articles

Trial in Progress: First Report of the Phase 1/2 Study of the Safety and Efficacy of CPO107, a Bispecific Agent Targeting CD20/CD47 in CD20 Expressing Non-Hodgkin Lymphoma (NHL)

Alan P. Skarbnik, Franklin L. Chen, Luke Mountjoy, Zaw Win Myint, Patricia A. Young, Andrew R. Whiteley, Steven Novick, Jennifer Su, Qingxi Wang, Kevin Romanko, Xi-De Wang, Yejia Li, Shulin Zhong, Liping Song, Ranjana H. Advani
Journal: Blood
Blood (2022) 140 (Supplement 1): 12059–12060.
https://doi.org/10.1182/blood-2022-164746
Published: 2022
Journal Articles

Decreased Chimeric Antigen Receptor T-Cell Efficacy with Severe or Prolonged Post-Infusion Cytopenias

Nadeem Tabbara, John Sharp, Daria Gaut, Kevin Tang, Thanh Pham, Caspian Oliai, Myung Sim, Patricia A. Young, Joshua Sasine
Journal: Blood
Blood (2021) 138 (Supplement 1): 3869.
https://doi.org/10.1182/blood-2021-154048
Published: 2021
Journal Articles

A Phase 1, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Intravenous Doses of IGN002 Administered Weekly to Subjects with Refractory Non-Hodgkin Lymphoma

Patricia A. Young, MD, Fabio D Mataveli, MDPhDMBA
Journal: Blood
Blood (2020) 136 (Supplement 1): 35.
https://doi.org/10.1182/blood-2020-137784
Published: 2020
Journal Articles

Granulocyte Colony-Stimulating Factor (G-CSF) Interactions with Chimeric Antigen Receptor (CAR) T-Cell Therapy for Diffuse Large B-Cell Lymphoma

Daria Gaut, MD, Kevin Tang, BS, BA, Myung Sim, PhD, Tuyen Duong, Joshua Sasine, MD PhD, Patricia A. Young, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4109.
https://doi.org/10.1182/blood-2019-122195
Published: 2019
Journal Articles

Consolidative High Dose Chemotherapy and Autologous Stem Cell Transplant for Patients with Primary Central Nervous System (CNS) Lymphoma or Non-Hodgkin Lymphoma with CNS Involvement Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning Regimen

Patricia A. Young, MD, Daria Gaut, MD, Davis A. Kimaiyo, Jonathan A. Grotts, John P Chute, MD, Gary J. Schiller, MD, John M. Timmerman, MD, Sven de Vos, Herbert A. Eradat, MD MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4611.
https://doi.org/10.1182/blood-2018-99-117225
Published: 2018
Journal Articles

Analysis of Programmed Death Ligand 1 (PD-L1) Expression in Diffuse Large B Cell Lymphomas (DLBCL) in HIV-Negative Versus HIV-Positive Patients

Chun Chao, PhD, Patricia A Young, MD, Lanfang Xu, PhD, Michael J. Silverberg, PhD MPH, Jonathan W. Said, MD, John M. Timmerman, MD
Journal: Blood
Blood (2015) 126 (23): 1462.
https://doi.org/10.1182/blood.V126.23.1462.1462
Published: 2015
Journal Articles

Antibody-Interferon-Alpha Fusion Protein Therapy for the Treatment of B-Cell Non-Hodgkin Lymphoma: Enhanced ADCC, Inhibition of Proliferation, and In Vivo Eradication of CD20+ Human Lymphomas

John M. Timmerman, MD, Kristopher K Steward, PhD, Reiko E Yamada, Patricia A Young, MD, Dena M. Minning, MD PhD, Raj K Sachdev, PhD, Michael J Gresser, PhD, Sanjay D Khare, PhD, Sherie L Morrison, PhD
Journal: Blood
Blood (2015) 126 (23): 2762.
https://doi.org/10.1182/blood.V126.23.2762.2762
Published: 2015